Julia Talsma is lead editor for Drug Topics magazine.
RxAlly has launched a new Performance Network of more than 20,000 pharmacies nationwide, with a core mission to generate measurable improvements in patient health outcomes and healthcare costs.
In February 2012, RxAlly launched its Performance Network of more than 20,000 pharmacies with a mission to generate measurable improvements in patient health outcomes while reducing healthcare costs. It is well on its way to launching an integrated platform to accomplish this goal - connecting all these pharmacies' data and aggregating it in a systematic way to address the challenges of lack of adherence.
"The only way to have pharmacy seen as a valuable player in healthcare is to have a large enough network, so that you can deliver a solution to the entire country," said Roberts, CEO of RxAlly and former executive vice president of the National Community Pharmacists Association (NCPA). Even Walgreens, the largest pharmacy chain in the world with 8,000 stores, recognized the need to be part of a larger network to play an enhanced role in healthcare, he continued.
Reimbursement continues to be a major challenge for pharmacies. In fact, the pharmacy model that is solely focused on the commodity itself is a very challenging business model in terms of survival in the current marketplace, Roberts noted.
"Our aim at RxAlly is to form a network of like-minded pharmacies that are focused on ensuring that prescription medicines are used correctly and with the technology in place to really clearly demonstrate the value of pharmacy," said Roberts.
Since its launch, RxAlly has added another 20 groups from regional chains and groups representing independents.
For more information, go to http://www.rxally.com.